Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference10 articles.
1. CD38 as an immunotherapeutic target in multiple myeloma;Bonello;Expert Opin Biol Ther,2018
2. MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial;Raab;Lancet Haematol,2020
3. Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma;Usmani;Blood,2016
4. Results from a phase II study of isatuximab as a single agent and in combination with dexamethasone in patients with relapsed/refractory multiple myeloma;Dimopoulos;Blood,2018
5. Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX;Dimopoulos;Haematologica,2018
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The emerging role of melflufen and peptide-conjugates in multiple myeloma;Current Opinion in Oncology;2024-08-22
2. Exogenous Antigen Upregulation Empowers Antibody Targeted Nanochemotherapy of Leukemia;Advanced Materials;2023-06-30
3. Exogenous CD38 upregulation enables high-efficacy dually cascade targeted molecular therapy of leukemia;Nano Today;2023-06
4. Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression;World Journal of Stem Cells;2023-05-26
5. Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma;Current Oncology;2022-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3